99198-80-8

Basic information

• Product Name: 1-CBZ-4-(3-HYDROXY-PROPYL)-PIPERIDINE
• Synonyms: 4-(3-HYDROXY-PROPYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER;1-CBZ-4-(3-HYDROXY-PROPYL)-PIPERIDINE;N-CBZ-3-(piperidin-4-yl)propan-1-ol;benzyl 4-(2-hydroxypropyl)-1-piperidinecarboxylate;Benzyl 4-(3-hydroxypropyl)piperidine-1-carboxylate
• CAS NO: 99198-80-8
• Molecular Formula: C₁₆H₂₃NO₃
• Molecular Weight: 277.36
• Mol File: 99198-80-8.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-CBZ-4-(3-HYDROXY-PROPYL)-PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-CBZ-4-(3-HYDROXY-PROPYL)-PIPERIDINE(99198-80-8)
• EPA Substance Registry System: 1-CBZ-4-(3-HYDROXY-PROPYL)-PIPERIDINE(99198-80-8)

Safety Data

• Hazardous Substances Data: 99198-80-8(Hazardous Substances Data)

Usage

General Description

1-CBZ-4-(3-hydroxy-propyl)-piperidine is a chemical compound with the molecular formula C17H26N2O3. It is a piperidine derivative and contains a hydroxypropyl group. 1-CBZ-4-(3-HYDROXY-PROPYL)-PIPERIDINE is often used in the synthesis of pharmaceuticals and other organic compounds. It has potential applications in the pharmaceutical industry due to its versatile chemical structure and reactivity. It is important to handle this compound with caution and adhere to proper safety protocols due to its potential hazards.

Upstream product

• 501-53-1 benzyl chloroformate 
• 156185-63-6 N-Boc-piperidin-4-yl-propanol 
• 7037-49-2 3-(piperidin-4-yl)propan-1-ol 

Downstream Products

• 566905-93-9 benzyl 4-{3-[bis(tert-butoxycarbonyl)amino]propyl}piperidine-N-carboxylate 
• 566906-01-2 2-(4-{3-[bis(tert-butoxycarbonyl)amino]propyl}piperidin-1-yl)ethyl 4 amino-5-chloro-2-methoxybenzoate 
• 461052-63-1 benzyl 4-[3-(3-{2-[(3-methoxy-2-{[(4-methyl-phenyl)-sulfonyl]amino}-3-oxopropyl)amino]-2-oxoethyl}-1H-1-indolyl)propyl]-1-piperidinecarboxylate 
• 461052-66-4 tert-butyl 4-[3-(3-{2-[(3-methoxy-2-{[(4-methylphenyl)sulfonyl]amino}-3-oxopropyl)amino]-2-oxo-ethyl}-1H-1-indolyl)propyl]-1-piperidinecarboxylate 
• 461052-67-5 3-{[2-(1-{3-[1-(tert-butyloxycarbonyl)-4-piperidyl]propyl}-1H-3-indolyl)acetyl]amino}-2-{[(4-methyl-phenyl)sulfonyl]amino}propanoic acid 
• 461052-64-2 3-{2-[1-(3-piperidin-4-yl-propyl)-1H-indol-3-yl]-acetylamino}-2-(toluene-4-sulfonylamino)-propionic acid methyl ester 
• 461052-42-6 4-(3-{3-[(E)-2-(2-Ethoxycarbonyl-ethylcarbamoyl)-vinyl]-indol-1-yl}-propyl)-piperidine-1-carboxylic acid benzyl ester 
• 461052-40-4 4-(3-{3-[(2-ethoxycarbonyl-ethylcarbamoyl)-methyl]-indol-1-yl}-propyl)-piperidine-1-carboxylic acid benzyl ester 
• 461052-44-8 4-(3-{3-[(E)-2-(2-Methoxycarbonyl-1-methyl-ethylcarbamoyl)-vinyl]-indol-1-yl}-propyl)-piperidine-1-carboxylic acid benzyl ester 
• 461052-30-2 benzyl 4-(3-{3-[(E)-3-ethoxy-3-oxo-1-propenyl]-1H-1-indolyl}-propyl)-1-piperidinecarboxylate 
• 461052-36-8 4-{3-[3-((E)-2-Carboxy-vinyl)-indol-1-yl]-propyl}-piperidine-1-carboxylic acid benzyl ester 
• 461052-26-6 4-[3-(3-methoxycarbonylmethyl-indol-1-yl)-propyl]-piperidine-1-carboxylic acid benzyl ester 
• 461052-34-6 4-[3-(3-carboxymethyl-indol-1-yl)-propyl]-piperidine-1-carboxylic acid benzyl ester 

Relevant articles and documents

ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE

Substituted aryl and heteroaryl ether compounds of the Formula (I) and pharmaceutically acceptable salts thereof, wherein X, R 1, R 2, R 3, L, R 4, L 1, Q, and R 5 are as defined herein. These compounds and pharmaceutically acceptable compositions comprising a compound thereof, are useful as Liver X-β receptor (LXRβ) agonists, and may be useful for treating or preventing pathologies related thereto. Such pathologies include, but are not limited to, inflammatory diseases and diseases characterized by defects in cholesterol and lipid metabolism, such as Alzheimer's disease.

ANTITHROMBOTIC AGENTS

This invention relates to thrombin inhibiting compounds having the FormulaIX--Y--NH--(CH 2) r--G I where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations containing those compounds and methods of their use as thrombin inhibitors, coagulation inhibitors, and thromboembolic disorder agents.

ANTITHROMBOTIC AGENTS

This invention relates to thrombin inhibiting compounds having the FormulaIX--Y--NH--(CH 2) r--G I where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations containing those compounds and methods of their use as thrombin inhibitors, coagulation inhibitors, and thromboembolic disorder agents.